Physician

Aisha Quama Thomas-St. Cyr, MD

According to 2025 Medicare claims, Aisha Cyr, MD (NPI: 1619153541) practices infectious disease in the Sebastian-Vero Beach-West Vero Corridor, FL market, with the plurality of this provider's patient population coming from Indian River, FL. This provider's primary affiliated billing organization is SEBASTIAN ID CARE LLC (NPI: 1497125413; TIN: 463744196) and primary practice location at 32958-3282.

Cyr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 320 traditional Medicare patients, billed 2,883 HCPCS/CPT codes, and received $177,057 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,462 prescription claims across 244 beneficiaries totaling $2,542,027 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). 2023 DME data shows 12 claims. Open Payments data shows 58 records totaling $1,330. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $354,007 to $2,542,027. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $9,975 and ending at $9,137.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	583	2,650	$220,410
2016	578	2,863	$205,161
2017	634	7,667	$235,172
2018	566	24,315	$204,511
2019	570	4,857	$182,382
2020	618	4,492	$249,770
2021	526	3,802	$262,796
2022	465	4,230	$260,819
2023	374	3,314	$209,265
2024	320	2,883	$177,057

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	167	688	$354,007
2016	162	724	$247,293
2017	188	1,021	$481,122
2018	235	1,331	$916,403
2019	220	1,418	$1,043,302
2020	217	1,426	$1,258,035
2021	229	1,629	$1,253,731
2022	201	1,728	$1,722,552
2023	217	2,092	$2,298,263
2024	244	2,462	$2,542,027

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	25	$46,092
2017	N/R	52	$55,499
2018	N/R	23	$26,506
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$1,044
2022	N/R	12	$1,017
2023	N/R	12	$825
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	80	91	$137
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	117	123	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	131	365	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	81	199	$72
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	155	554	$63

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	206	6,180	$771,210
Egrifta Sv	Tesamorelin Acetate	31	930	$222,593
Juluca	Dolutegravir/Rilpivirine	65	1,950	$215,059
Cabenuva	Cabotegravir/Rilpivirine	32	1,830	$206,870
Dovato	Dolutegravir Sodium/Lamivudine	55	1,642	$151,196

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	58	$1,330	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aisha Quama Thomas-St. Cyr, MD?

Tedicare shows public-source Medicare data for Aisha Quama Thomas-St. Cyr, MD (NPI 1619153541), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aisha Quama Thomas-St. Cyr, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aisha Quama Thomas-St. Cyr, MD?

Aisha Quama Thomas-St. Cyr, MD is linked to SEBASTIAN ID CARE LLC (billing NPI 1497125413) in the available physician profile data.

Does Aisha Quama Thomas-St. Cyr, MD have Open Payments data?

Aisha Quama Thomas-St. Cyr, MD has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.